Literature DB >> 22492998

Forkhead box protein p1 is a transcriptional repressor of immune signaling in the CNS: implications for transcriptional dysregulation in Huntington disease.

Bin Tang1, Kristina Becanovic, Paula A Desplats, Brian Spencer, Austin M Hill, Colum Connolly, Eliezer Masliah, Blair R Leavitt, Elizabeth A Thomas.   

Abstract

Forkhead box protein p1 (Foxp1), a transcription factor showing highly enriched expression in the striatum, has been implicated in central nervous system (CNS) development, but its role in the mature brain is unknown. In order to ascertain functional roles for Foxp1 in the CNS, we have identified gene targets for Foxp1 both in vitro and in vivo using genome-wide expression microarrays and chromatin-immunoprecipitation followed by high-throughput sequencing (ChIP-seq) assays. We found that mouse Foxp1 overexpression in striatal cells elicited expression changes of genes related to immune signaling, transcriptional regulation and a manually curated Huntington's disease (HD)-signaling pathway. Similar results were found when the gene expression data set was integrated with Foxp1-binding data determined from ChIP-seq analysis. In vivo lentiviral-mediated overexpression of human FOXP1 in the context of mutant huntingtin (Htt) protein resulted in a robust downregulation of glial cell-associated, immune genes, including those encoding a variety of cytokines and chemokines. Furthermore, Foxp1-induced expression changes were significantly negatively correlated with those changes elicited by mutant Htt protein in several different HD mouse models, and most significantly in post-mortem caudate from human HD subjects. We finally show that Foxp1 interacts with mutant Htt protein in mouse brain and is present in nuclear Htt aggregates in the striatum of R6/1 transgenic mice. These findings implicate Foxp1 as a key repressor of immune signaling in the CNS and suggest that the loss of Foxp1-mediated gene regulation in HD contributes to the immune dysfunction in this disease. We further suggest that Foxp1-regulated pathways might be important mediators of neuronal-glial cell communication.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492998      PMCID: PMC3384380          DOI: 10.1093/hmg/dds132

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  70 in total

Review 1.  Lymphoid malignancies: the dark side of B-cell differentiation.

Authors:  A L Shaffer; Andreas Rosenwald; Louis M Staudt
Journal:  Nat Rev Immunol       Date:  2002-12       Impact factor: 53.106

2.  Expression of Foxp2, a gene involved in speech and language, in the developing and adult striatum.

Authors:  Kaoru Takahashi; Fu-Chin Liu; Katsuiku Hirokawa; Hiroshi Takahashi
Journal:  J Neurosci Res       Date:  2003-07-01       Impact factor: 4.164

3.  In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons.

Authors:  Elizabeth A Thomas; Giovanni Coppola; Bin Tang; Alexandre Kuhn; SoongHo Kim; Daniel H Geschwind; Timothy B Brown; Ruth Luthi-Carter; Michelle E Ehrlich
Journal:  Hum Mol Genet       Date:  2010-12-20       Impact factor: 6.150

Review 4.  NF-kappaB in neuronal plasticity and neurodegenerative disorders.

Authors:  M P Mattson; S Camandola
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

Review 5.  Forkhead transcription factors: key players in development and metabolism.

Authors:  Peter Carlsson; Margit Mahlapuu
Journal:  Dev Biol       Date:  2002-10-01       Impact factor: 3.582

6.  The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p.

Authors:  A H Banham; N Beasley; E Campo; P L Fernandez; C Fidler; K Gatter; M Jones; D Y Mason; J E Prime; P Trougouboff; K Wood; J L Cordell
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

7.  A forkhead-domain gene is mutated in a severe speech and language disorder.

Authors:  C S Lai; S E Fisher; J A Hurst; F Vargha-Khadem; A P Monaco
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

8.  Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis.

Authors:  Kristina Becanovic; Mahmoud A Pouladi; Raymond S Lim; Alexandre Kuhn; Paul Pavlidis; Ruth Luthi-Carter; Michael R Hayden; Blair R Leavitt
Journal:  Hum Mol Genet       Date:  2010-01-20       Impact factor: 6.150

9.  FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease.

Authors:  Bin Li; Arabinda Samanta; Xiaomin Song; Kathryn T Iacono; Patrick Brennan; Talal A Chatila; Giovanna Roncador; Alison H Banham; James L Riley; Qiang Wang; Yuan Shen; Sandra J Saouaf; Mark I Greene
Journal:  Int Immunol       Date:  2007-06-22       Impact factor: 4.823

Review 10.  Long-range control of gene expression: emerging mechanisms and disruption in disease.

Authors:  Dirk A Kleinjan; Veronica van Heyningen
Journal:  Am J Hum Genet       Date:  2004-11-17       Impact factor: 11.025

View more
  25 in total

1.  Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.

Authors:  K K Wong; D M Gascoyne; P J Brown; E J Soilleux; C Snell; H Chen; L Lyne; C H Lawrie; R D Gascoyne; L M Pedersen; M B Møller; K Pulford; D Murphy; T M Green; A H Banham
Journal:  Leukemia       Date:  2013-07-25       Impact factor: 11.528

2.  Genome-wide Analysis of RARβ Transcriptional Targets in Mouse Striatum Links Retinoic Acid Signaling with Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Anna Niewiadomska-Cimicka; Agnieszka Krzyżosiak; Tao Ye; Anna Podleśny-Drabiniok; Doulaye Dembélé; Pascal Dollé; Wojciech Krężel
Journal:  Mol Neurobiol       Date:  2016-07-12       Impact factor: 5.590

3.  Human mutant huntingtin disrupts vocal learning in transgenic songbirds.

Authors:  Wan-Chun Liu; Jessica Kohn; Sarah K Szwed; Eben Pariser; Sharon Sepe; Bhagwattie Haripal; Naoki Oshimori; Martin Marsala; Atsushi Miyanohara; Ramee Lee
Journal:  Nat Neurosci       Date:  2015-10-05       Impact factor: 24.884

Review 4.  The Oligomer Hypothesis in α-Synucleinopathy.

Authors:  Kenjiro Ono
Journal:  Neurochem Res       Date:  2017-08-21       Impact factor: 3.996

5.  FOXP1 acts through a negative feedback loop to suppress FOXO-induced apoptosis.

Authors:  R van Boxtel; C Gomez-Puerto; M Mokry; A Eijkelenboom; K E van der Vos; E E S Nieuwenhuis; B M T Burgering; E W-F Lam; P J Coffer
Journal:  Cell Death Differ       Date:  2013-07-05       Impact factor: 15.828

6.  Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.

Authors:  Anto Sam Crosslee Louis Sam Titus; Tanzeen Yusuff; Marlène Cassar; Elizabeth Thomas; Doris Kretzschmar; Santosh R D'Mello
Journal:  J Neurosci       Date:  2017-05-26       Impact factor: 6.167

Review 7.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

8.  Downregulation of FOXP1 is required during germinal center B-cell function.

Authors:  Ainara Sagardoy; Jose I Martinez-Ferrandis; Sergio Roa; Karen L Bunting; María Angela Aznar; Olivier Elemento; Rita Shaknovich; Lorena Fontán; Vicente Fresquet; Ignacio Perez-Roger; Eloy F Robles; Linde De Smedt; Xavier Sagaert; Ari Melnick; Jose A Martinez-Climent
Journal:  Blood       Date:  2013-04-11       Impact factor: 22.113

9.  FOXP1 negatively regulates intrinsic excitability in D2 striatal projection neurons by promoting inwardly rectifying and leak potassium currents.

Authors:  Sheridan Cavalier; Volodymyr Rybalchenko; Nitin Khandelwal; Ashwinikumar Kulkarni; Ashley G Anderson; Genevieve Konopka; Jay R Gibson
Journal:  Mol Psychiatry       Date:  2021-01-05       Impact factor: 13.437

10.  Increased gene expression of FOXP1 in patients with autism spectrum disorders.

Authors:  Wei-Hsien Chien; Susan Shur-Fen Gau; Chun-Houh Chen; Wen-Che Tsai; Yu-Yu Wu; Po-Hsu Chen; Chi-Yung Shang; Chia-Hsiang Chen
Journal:  Mol Autism       Date:  2013-07-01       Impact factor: 7.509

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.